Predictive value of NT-pro BNP after acute myocardial infarction: Relation with acute and chronic infarct size and myocardial function

International Journal of Cardiology

Volumn 147, Issue 1, 2011, Pages 118-123

  Mayr, Agnes ^a   Mair, Johannes ^a   Schocke, Michael ^a   Klug, Gert ^a   Pedarnig, Kathrin ^a   Haubner, Bernhard Johannes ^a   Nowosielski, Martha ^a   Grubinger, Thomas ^a   Pachinger, Otmar ^a   Metzler, Bernhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Acute and chronic myocardial infarction; Cardiac magnetic resonance; Infarct size; NT pro BNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ANGIOPLASTY; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL STATUS; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE NECROSIS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS;

EID: 79951720838     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.09.537     Document Type: Article

References (43)

1. Becker LC, Silverman KJ, Bulkley BH, Kallman CH, Mellits ED, Weisfeldt M. Comparison of early thallium-201 scintigraphy and gated blood pool imaging for predicting mortality in patients with acute myocardial infarction. Circulation Jun 1983;67(6):1272-82. (Pubitemid 13105350)
2. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation Aug 1 1995;92(3):334-41.
3. Kroll D, Farah W, McKendall GR, Reinert SE, Johnson LL. Prognostic value of stress-gated Tc-99 m sestamibi SPECT after acute myocardial infarction. Am J Cardiol Feb 15 2001;87(4):381-6. (Pubitemid 32149993)
4. Kaul S. Assessing the myocardium after attempted reperfusion: should we bother? Circulation Aug 18 1998;98(7):625-7.
5. Panteghini M, Cuccia C, Bonetti G, Pagani F, Giubbini R, Bonini E. Rapid determination of brain natriuretic peptide in patients with acute myocardial infarction. Clin Chem Lab Med Feb 2003;41(2):164-8. (Pubitemid 36336706)
6. Nakagawa K, Umetani K, Fujioka D, et al. Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium- 201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction. Circ J Oct 2004;68(10):923-7. (Pubitemid 39410217)
7. Klug G, Trieb T, Schocke M, et al. Quantification of regional functional improvement of infarcted myocardium after primary PTCA by contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging Feb 2009;29(2):298-304.
8. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation Nov 9 1999;100(19):1992-2002. (Pubitemid 29529292)
9. Ibrahim T, Nekolla SG, Hornke M, et al. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99msestamibi. J Am Coll Cardiol Feb 15 2005;45(4):544-52. (Pubitemid 40222249)
10. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol Apr 18 2006;47(8):1641-5.
11. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS. The quantification of infarct size. J Am Coll Cardiol Oct 19 2004;44(8):1533-42. (Pubitemid 39377707)
12. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation Jun 12 2001;103(23):2780-3. (Pubitemid 32550063)
13. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet Feb 1 2003;361(9355):374-9. (Pubitemid 36164969)
14. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet Jul 26 2003;362(9380):316-22. (Pubitemid 36936846)
15. Staub D, Nusbaumer C, Zellweger MJ, et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J Jun 2006;151(6):1223-30. (Pubitemid 43866600)
16. Sabatine MS, Morrow DA, de Lemos JA, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol Nov 16 2004;44(10):1988-95. (Pubitemid 39473283)
17. Weber M, Dill T, Arnold R, et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J Oct 2004;148(4):612-20. (Pubitemid 39349380)
18. Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation Sep 15 1995;92(6):1558-64.
19. Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun Sep 25 1995;214(3):1175-83.
20. Richards AM, Doughty R, Nicholls MG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol Jun 1 2001;37(7):1781-7. (Pubitemid 32499959)
21. Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol Feb 15 2002;89(4):463-5. (Pubitemid 34142525)
22. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol Sep 2000;36(3):959-69.
23. Richards AM, Nicholls MG, Yandle TG, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction The Christchurch Cardioendocrine Research Group. Heart (Br Card Soc) Feb 1999;81(2):114-20. (Pubitemid 29119383)
24. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation Jan 29 2002;105(4):539-42. (Pubitemid 34262671)
25. Schocke MF, Esterhammer R, Ostermann S, et al. High-energy phosphate metabolism during calf ergometry in patients with isolated aorto-iliac artery stenoses. Invest Radiol Dec 2006;41(12):874-82. (Pubitemid 44747115)
26. Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol Sep 3 2003;42(5):895-901. (Pubitemid 37059750)
27. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med Nov 16 2000;343(20):1445-53.
28. Bondarenko O, Beek AM, Hofman MB, et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005;7(2):481-5. (Pubitemid 40563339)
29. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol Sep 1997;47(3):287-96. (Pubitemid 27395959)
30. Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail Mar 15 2004;6(3):295-300. (Pubitemid 38253048)
31. Xiaozhou H, Jie Z, Li Z, Liyan C. Predictive value of the serum level of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in left ventricular remodeling after acute myocardial infarction. J Clin Lab Anal 2006;20(1):19-22. (Pubitemid 43346887)
32. Nilsson JC, Groenning BA, Nielsen G, et al. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. Am Heart J Apr 2002;143(4):696-702. (Pubitemid 34454704)
33. Ndrepepa G, Braun S, Mehilli J, et al. N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis. Am J Cardiol Apr 15 2006;97(8):1151-6.
34. Galvani M, Ottani F, Oltrona L, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation Jul 13 2004;110(2):128-34. (Pubitemid 38924580)
35. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation Apr 1990;81(4):1161-72.
36. Cochet A, Zeller M, Cottin Y, et al. The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction. Eur J Heart Fail Aug 2004;6(5):555-60. (Pubitemid 39070508)
37. Steen H, Futterer S, Merten C, Junger C, Katus HA, Giannitsis E. Relative role of NTpro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. J Cardiovasc Magn Reson 2007;9(5):749-58. (Pubitemid 47463901)
38. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol Jun 16 2004;43(12):2253-9. (Pubitemid 38757594)
39. Choi CJ, Haji-Momenian S, Dimaria JM, et al. Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction. J Cardiovasc Magn Reson 2004;6(4):917-25. (Pubitemid 40041296)
40. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol Mar 1 2000;35(3):569-82. (Pubitemid 30167013)
41. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation May 19 1998;97(19):1921-9.
42. Bonarjee VV, Carstensen S, Caidahl K, Nilsen DW, Edner M, Berning J. Attenuation of left ventricular dilatation after acute myocardial infarction by early initiation of enalapril therapy CONSENSUS II Multi-Echo Study Group. Am J Cardiol Nov 1 1993;72(14):1004-9. (Pubitemid 23319921)
43. Coats AJ. Ethical authorship and publishing. Int J Cardiol Jan 9 2009;131(2):149-50.